Clinical Policy: Cosmetic and Reconstructive Procedures Form

Chat with GenHealth to automate any policy or prior auth task.


Clinical Policy: Cosmetic and Reconstructive Procedures

Indications

(10001) Is the procedure performed to improve the function of an abnormal body part? 
(10002) Is the abnormal body part caused by illness? 
(10003) Is the abnormal body part caused by trauma? 
(10004) Is the abnormal body part caused by a congenital defect? 
(10005) Is the procedure performed after failure of conservative therapy? 

YesNoN/A
YesNoN/A
YesNoN/A

Sign up to see the rest of the questions

Unlock the remaining questions and the full coverage workflow.

Sign up for free
Effective Date

NA

Last Reviewed

NA

Original Document

  Reference



CENTENE® Corporation

Clinical Policy: Cosmetic and Reconstructive Procedures Reference Number: CP.MP.31 Date of Last Revision: 08/24 Coding Implications

                                                     Revision Log

See Important Reminder at the end of this policy for important regulatory and legal information.

Description Reconstructive surgery is performed on abnormal structures of the body caused by congenital defects, developmental abnormalities, trauma, surgery, infection, tumors or disease.¹⁶

This policy outlines the medical necessity criteria for cosmetic and reconstructive procedures.

Note: • For criteria applicable to Medicare plans, please see MC.CP.MP.31 Cosmetic and

Reconstructive Procedures.

• This policy should only be used if there is no health plan-adopted nationally recognized

decision support criteria.

• Please refer to CP.MP.95 Gender Affirming procedures for procedures related to

treatment of gender dysphoria.

Policy/Criteria

A.  Intent of the procedure meets one of the following:
    1.  The procedure is performed to improve the function of an abnormal body part caused
        by illness, trauma, or a congenital defect after failure of conservative therapy (unless
        conservative therapy is not standard of care for the condition, or is contraindicated);
    2.  Skin tag removal when located in an area that affects eyesight or in an area of friction
        with documentation of repeated irritation and bleeding (refer to Benefit Plan Contract
        for any coverage restrictions);
    3.  Scar/keloid revision/removal when accompanied by pain unresponsive to
        conservative therapy and is recurrently infected, unstable, friable; or with functional
        impairment;
    4.  Certain reconstructive procedures may be covered if improving appearance is the
        only benefit, e.g. post-mastectomy breast reconstruction. These procedures may
        include, but are not limited to:
        a.  Post-mastectomy, medically necessary lumpectomy, or other medically necessary
            breast surgery resulting in asymmetry; breast reconstruction, including nipple
            reconstruction, tattooing and surgery on contralateral breast to restore symmetry;
        b.  Use of FDA-approved facial dermal injections [Poly-L-Lactic acid (Sculptra™),
            calcium hydroxylapatite microspheres (Radiesse®)] or autologous fat transfers for
            HIV-associated wasting* when meeting both of the following:

II. It is the policy of Health Plans affiliated with Centene Corporation that cosmetic surgery is

not medically necessary and generally not a covered benefit when performed to improve a
patient’s normal appearance and self-esteem. These procedures include, but are not limited
to:
A.  Excision of excessive skin
B.  Body contouring
C.  Body lift
D.  Breast augmentation
E.  Liposuction, excluding lipoma as directed by clinical decision support criteria
F.  Surgery to correct unsatisfactory results from previous cosmetic and/or non-covered
    service
G.  Revision, removal, or replacement of breast implants previously placed for cosmetic
    reasons
H.  Removal of excess skin or body contouring procedures following weight loss or bariatric
    surgery when removal is solely cosmetic
I.  Facial augmentation
J.  Abdominoplasty
K.  Dermabrasion
L.  Skin rejuvenation and resurfacing
M.  Electrolysis, laser hair removal
N.  Hair transplantation, when not performed to correct permanent hair loss caused by
    disease or injury
O.  Tattooing (except when covered for breast reconstruction post-mastectomy)
P.  Injectable filler
Q.  Circumcision revisions done only to improve appearance
R.  Mastopexy (except for breast reconstruction post-mastectomy, medically necessary
    lumpectomy, or other medically necessary breast surgery resulting in significant
    asymmetry)
S.  Correction of inverted nipples
T.  Repair of diastasis recti
U.  Breast reconstruction for fibroadenomas or other benign lesions, unless medically
    necessary per clinical decision support criteria.

Background Reconstructive surgery is performed on abnormal structures of the body caused by congenital defects, developmental abnormalities, previous or concurrent surgeries, trauma, infection, tumors or disease. It is generally performed to improve the functioning of a body part and may or may not restore a normal appearance.² Functional impairment is a health condition in which the normal function of a part of the body or organ system is less than age appropriate at full capacity, such as decreased range of motion, diminished eyesight or hearing, etc. that variably impacts activities of daily living.³

Cosmetic surgery is performed to reshape normal structures of the body in order to improve the appearance and self-esteem of a patient. It is generally considered not medically necessary.¹

Coding Implications This clinical policy references Current Procedural Terminology (CPT®). CPT® is a registered trademark of the American Medical Association. All CPT codes and descriptions are copyrighted 2023, American Medical Association. All rights reserved. CPT codes and CPT descriptions are from the current manuals and those included herein are not intended to be all-inclusive and are included for informational purposes only. Codes referenced in this clinical policy are for informational purposes only. Inclusion or exclusion of any codes does not guarantee coverage. Providers should reference the most up-to-date sources of professional coding guidance prior to the submission of claims for reimbursement of covered services.

CPT Codes That Support Coverage Criteria

CPT Codes Description
11200 Removal of skin tags, multiple fibrocutaneous tags, any area; up to and including 15 lesions
11201 Removal of skin tags, multiple fibrocutaneous tags, any area; each additional 10 lesions, or part thereof (List separately in addition to code for primary procedure)
11400 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 0.5 cm or less
11401 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 0.6 to 1.0 cm
11402 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 1.1 to 2.0 cm
11403 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 2.1 to 3.0 cm
11404 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter 3.1 to 4.0 cm
11406 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), trunk, arms or legs; excised diameter over 4.0 cm
11420 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 0.5 cm or less
11421 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 0.6 to 1.0 cm
11422 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 1.1 to 2.0 cm
11423 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 2.1 to 3.0 cm
11424 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 3.1 to 4.0 cm
11426 Excision, benign lesion including margins, except skin tag (unless listed elsewhere), scalp, neck, hands, feet, genitalia; excised diameter over 4.0 cm
11440 Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 0.5 cm or less
11441 Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 0.6 to 1.0 cm
11442 Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 1.1 to 2.0 cm
11443 Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 2.1 to 3.0 cm
11444 Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 3.1 to 4.0 cm
11446 Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter over 4.0 cm
11920 Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.0 sq cm or less
11921 Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.1 to 20.0 sq cm
11922 Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure)
15773 Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, and/or feet; 25 cc or less injectate
15774 Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, and/or feet; each additional 25 cc injectate, or part thereof (List separately in addition to code for primary procedure)
15788 Chemical peel, facial; epidermal
15789 Chemical peel, facial; dermal
15792 Chemical peel, nonfacial; epidermal
15793 Chemical peel, nonfacial; dermal
15830 Excision, excessive skin and subcutaneous tissue (includes lipectomy); abdomen, infraumbilical panniculectomy
15832 Excision, excessive skin and subcutaneous tissue (includes lipectomy); thigh
15833 Excision, excessive skin and subcutaneous tissue (includes lipectomy); leg
15834 Excision, excessive skin and subcutaneous tissue (includes lipectomy); hip
15835 Excision, excessive skin and subcutaneous tissue (includes lipectomy); buttock
15836 Excision, excessive skin and subcutaneous tissue (includes lipectomy); arm
15837 Excision, excessive skin and subcutaneous tissue (includes lipectomy); forearm or hand
15220 Full thickness graft, free, including direct closure of donor site, scalp, arms, and/or legs; 20 sq cm or less
15221 Full thickness graft, free, including direct closure of donor site, scalp, arms, and/or legs; each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure)
15771 Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; 50 cc or less injectate
15772 Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; each additional 50 cc injectate, or part thereof (List separately in addition to code for primary procedure)
15775 Punch graft for hair transplant; 1 to 15 punch grafts
15776 Punch graft for hair transplant; more than 15 punch grafts
15838 Excision, excessive skin and subcutaneous tissue (includes lipectomy); submental fat pad
15839 Excision, excessive skin and subcutaneous tissue (includes lipectomy); other area
15847 Excision, excessive skin and subcutaneous tissue (includes lipectomy), abdomen (eg, abdominoplasty) (includes umbilical transposition and fascial plication) (List separately in addition to code for primary procedure)
15876 Suction assisted lipectomy; head and neck
15877 Suction assisted lipectomy; trunk
15878 Suction assisted lipectomy; upper extremity
15879 Suction assisted lipectomy; lower extremity
15792 Chemical peel, nonfacial; epidermal
15793 Chemical peel, nonfacial; dermal
17110 Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettment), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions
17111 Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettment), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions
19301 Mastectomy, partial (eg, lumpectomy, tylectomy, quadrantectomy, segmentectomy);
19302 Mastectomy, partial (eg, lumpectomy, tylectomy, quadrantectomy, segmentectomy); with axillary lymphadenectomy
19303 Mastopexy, simple, complete
19316 Mastectomy, simple, complete
19318 Breast reduction
19325 Breast augmentation with implant
19328 Removal of intact breast implant
19330 Removal of ruptured breast implant, including implant contents (eg, saline, silicone gel)
19340 Insertion of breast implant on same day of mastectomy (ie, immediate)
19342 Insertion or replacement of breast implant on separate day from mastectomy
19350 Nipple/areola reconstruction
19355 Correction of inverted nipples
19357 Tissue expander placement in breast reconstruction, including subsequent expansion(s)
19361 Breast reconstruction; with latissimus dorsi flap
19364 Breast reconstruction; with free flap (eg, fTRAM, DIEP, SIEA, GAP flap)
19367 Breast reconstruction; with single-pedicle transverse rectus abdominis myocutaneous (TRAM) flap
19368 Breast reconstruction; with single-pedicle transverse rectus abdominis myocutaneous (TRAM) flap, requiring separate microvascular anastomosis (supercharging)
19369 Breast reconstruction; with bipedicle transverse rectus abdominis myocutaneous (TRAM) flap
19370 Revision of peri-implant capsule, breast, including capsulotomy, capsulorrhaphy, and/or partial capsulectomy
19371 Peri-implant capsulectomy, breast, complete, including removal of all intracapsular contents
19380 Revision of reconstructed breast (eg, significant removal of tissue, re-advancement and/or re-inset of flaps in autologous reconstruction or significant capsular revision combined with soft tissue excision in implant-based reconstruction)
19396 Preparation of moulage for custom breast implant
19499 Unlisted procedure, breast
21120 Genioplasty; augmentation (autograft, allograft, prosthetic material)
21121 Genioplasty; sliding osteotomy, single piece
21122 Genioplasty; sliding osteotomies, 2 or more osteotomies (eg, wedge excision or bone wedge reversal for asymmetrical chin)
21123 Genioplasty; sliding, augmentation with interpositional bone grafts (includes obtaining autografts)
21137 Reduction forehead; contouring only
21138 Reduction forehead; contouring and application of prosthetic material or bone graft (includes obtaining autograft)
21139 Reduction forehead; contouring and setback of anterior frontal sinus wall
21159 Reconstruction midface, LeFort III (extra and intracranial) with forehead advancement (eg, mono bloc), requiring bone grafts (includes obtaining autografts); without LeFort I
21160 Reconstruction midface, LeFort III (extra and intracranial) with forehead advancement (eg, mono bloc), requiring bone grafts (includes obtaining autografts); with LeFort I
21172 Reconstruction superior-lateral orbital rim and lower forehead, advancement or alteration, with or without grafts (includes obtaining autografts)
21175 Reconstruction, bifrontal, superior-lateral orbital rims and lower forehead, advancement or alteration (eg,plagiocephaly, trigonocephaly, brachycephaly), with or without grafts (includes obtaining autografts)
21179 Reconstruction, entire or majority of forehead and/or supraorbital rims; with grafts (allograft or prosthetic material)
21180 Reconstruction, entire or majority of forehead and/or supraorbital rims; with autograft (includes obtaining grafts)
21181 Reconstruction by contouring of benign tumor of cranial bones (eg, fibrous dysplasia), extracranial
21182 Reconstruction of orbital walls, rims, forehead, nasoethmoid complex following intra- and extracranial excision of benign tumor of cranial bone (eg, fibrous dysplasia), with multiple autografts (includes obtaining grafts); total area of bone grafting less than 40 sq cm
21183 Reconstruction of orbital walls, rims, forehead, nasoethmoid complex following intra- and extracranial excision of benign tumor of cranial bone (eg, fibrous dysplasia), with multiple autografts (includes obtaining grafts); total area of bone grafting greater than 40 sq cm but less than 80 sq cm
21184 Reconstruction of orbital walls, rims, forehead, nasoethmoid complex following intra- and extracranial excision of benign tumor of cranial bone (eg, fibrous dysplasia), with multiple autografts (includes obtaining grafts); total area of bone grafting greater than 80 sq cm
21230 Graft; rib cartilage, autogenous, to face, chin, nose or ear (includes obtaining graft)
21235 Graft; ear cartilage, autogenous, to nose or ear (includes obtaining graft)
21255 Reconstruction of zygomatic arch and glenoid fossa with bone and cartilage (includes obtaining autografts)
21256 Reconstruction of orbit with osteotomies (extracranial) and with bone grafts (includes obtaining autografts) (eg, micro-ophthalmia)
21260 Periorbital osteotomies for orbital hypertelorism, with bone grafts; extracranial approach
21261 Periorbital osteotomies for orbital hypertelorism, with bone grafts; combined intra- and extracranial approach
21263 Periorbital osteotomies for orbital hypertelorism, with bone grafts; with forehead advancement
21267 Orbital repositioning, periorbital osteotomies, unilateral, with bone grafts; extracranial approach
21268 Orbital repositioning, periorbital osteotomies, unilateral, with bone grafts; combined intra- and extracranial approach
21270 Malar augmentation, prosthetic material
21275 Secondary revision of orbitocraniofacial reconstruction
21280 Medial canthopexy (separate procedure)
21282 Lateral canthopexy
21295 Reduction of masseter muscle and bone (eg, for treatment of benign masseteric hypertrophy); extraoral approach
21296 Reduction of masseter muscle and bone (eg, for treatment of benign masseteric hypertrophy); intraoral approach
61550 Craniectomy for craniosynostosis; single cranial suture
61552 Craniectomy for craniosynostosis; multiple cranial sutures
61556 Craniotomy for craniosynostosis; frontal or parietal bone flap
61557 Craniotomy for craniosynostosis; bifrontal bone flap
61558 Extensive craniectomy for multiple cranial suture craniosynostosis (eg, cloverleaf skull); not requiring bone grafts
61559 Extensive craniectomy for multiple cranial suture craniosynostosis (eg, cloverleaf skull); recontouring with multiple osteotomies and bone autografts (e.g., barrel-stave procedure) (includes obtaining grafts)
HCPCS Description
G0429 Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (LDS) as a result of highly active antiretroviral therapy)
Q2026 Injection, Radiesse, 0.1 ml
Q2028 Injection, Sculptra, 0.5 mg
Reviews, Revisions, and Approvals Revision Date Approval Date
Original creation 03/09 03/09
Removed “significant” in I.A.4.a. In II. N. changed “hair replacement” to “hair transplantation.” Added additional not medically necessary indications i.e., (mastopexy except for breast reconstruction post-mastectomy or lumpectomy resulting in significant asymmetry, correction of inverted nipples, and repair of diastasis recti. Specialist reviewed. References reviewed and updated. 02/20 03/20
Added criteria for dermal injections and autologous fat injections for HIV-associated FLS. Changed policy title and medical necessity statements to state “cosmetic procedures” or “reconstructive procedures” instead of “cosmetic surgery” or “reconstructive surgery.” Added CPT and HCPCS codes for specified medically necessary indications. Added note to refer to CP.MP.95 Gender Affirming procedures for procedures related to treatment of gender dysphoria 04/20 05/20
Clarified in IIN. that hair transplant is not medically necessary, when not performed to correct permanent hair loss caused by disease or injury. Added the following applicable CPT codes: 15220,15221, 15775, 15776. Supporting references added. 09/20 09/20
Added applicable CPT codes: 15771, 15772. 01/21 03/21
Annual review. Reviewed and updated references. CPT code description revised in 2021: 19318, 19325, 19328, 19340, 19342, 19357, 19361 19364, 19367, 19368, 19369, 19370, 19371, and 19380. CPT 19324 and 19366 deleted in 2021. 03/21 03/21
Clarified in I.A.1. failure of conservative therapy “(unless conservative therapy is not standard of care for the condition, or is contraindicated).” 08/21 08/21
Changed “review date” in the header to “date of last revision” and “date” in the revision log header to “revision date.” Added the following codes from the retired Craniofacial Surgery policy: 21120, 21121, 21122, 21123, 21137, 21138, 21139, 21159, 21160, 21172, 21175, 21179, 21180, 21181, 21182, 21183, 21184, 21230, 21235, 21255, 21256, 21260, 21263, 21267, 21268, 21270, 21275, 21280, 21282, 21295, 21296, and craniectomy/craniotomy codes for craniosynostosis. 08/21 08/21
Clarified in I.A.4.a. “Post-mastectomy,* medically necessary lumpectomy, or other medically necessary breast surgery.” Updated IIR. “Mastopexy (except for breast reconstruction post-mastectomy, medically necessary lumpectomy, other medically necessary breast surgery resulting in significant asymmetry). In IIE., changed “InterQual” to “Decision Support Criteria.” Added II.U. “Breast reconstruction for fibroadenomas or other benign lesions, unless medically necessary per clinical decision support criteria” to not medically necessary procedures. Added codes 19330 and 19499. Annual review. References reviewed, updated, and reformatted. 10/21 10/21
Annual review completed. Added to I.A.4.b. “poly-L-lactic acid” and “calcium hydroxylapatite microspheres”. Minor rewording with no clinical significance. References reviewed and updated. Reviewed by external specialist. 10/22 10/22
Annual review. Minor edits to I.A.4.b with no clinical significance. Updated pharmacy policies for Serostim (somatropin) in note. Removed CPT code 11310. References reviewed and updated. Reviewed by internal specialist. 10/23 10/23
  1. Oh SJ, Koh SH, Lee JW, Jang YC. Expanded flap and hair follicle transplantation for reconstruction of postburn scalp alopecia. J Craniofac Surg. 2010;21(6):1737 to 1740. doi:10.1097/SCS.0b013e3181f403cc
  2. Yoo H, Moh J, Park JU. Treatment of Postsurgical Scalp Scar Deformity Using Follicular Unit Hair Transplantation. Biomed Res Int. 2019;2019:3423657. Published 2019 May 13. doi:10.1155/2019/3423657
  3. Women's Health Care and Cancer Rights Act (WHCRA). Centers of Medicare & Medicaid Services website. https://www.cms.gov/cioio/programs-and-initiatives/other-insurance- protections/whcra_fact sheet Published 1998. Modified 9/6/2023. Accessed June 21, 2024.
  4. Nahabedian M. Complications of reconstructive and aesthetic breast surgery. UpToDate. www.uptodate.com Updated April 12, 2023. Accessed June 21, 2024.
  5. Lee BT, Agarwal JP, Ascherman JA, et al. Evidence-Based Clinical Practice Guideline: Autologous Breast Reconstruction with DIEP or Pedicled TRAM Abdominal Flaps. Plast Reconstr Surg. 2017;140(5):651e to 664e. doi:10.1097/PRS.0000000000003768

Important Reminder

This clinical policy has been developed by appropriately experienced and licensed health care professionals based on a review and consideration of currently available generally accepted standards of medical practice; peer-reviewed medical literature; government agency/program approval status; evidence-based guidelines and positions of leading national health professional organizations; views of physicians practicing in relevant clinical areas affected by this clinical policy; and other available clinical information. The Health Plan makes no representations and accepts no liability with respect to the content of any external information used or relied upon in developing this clinical policy. This clinical policy is consistent with standards of medical practice current at the time that this clinical policy was approved. “Health Plan” means a health plan that has adopted this clinical policy and that is operated or administered, in whole or in part, by Centene Management Company, LLC, or any of such health plan’s affiliates, as applicable.

The purpose of this clinical policy is to provide a guide to medical necessity, which is a component of the guidelines used to assist in making coverage decisions and administering benefits. It does not constitute a contract or guarantee regarding payment or results. Coverage decisions and the administration of benefits are subject to all terms, conditions, exclusions and limitations of the coverage documents (e.g., evidence of coverage, certificate of coverage, policy, contract of insurance, etc.), as well as to state and federal requirements and applicable Health Plan-level administrative policies and procedures.

This clinical policy is effective as of the date determined by the Health Plan. The date of posting may not be the effective date of this clinical policy. This clinical policy may be subject to applicable legal and regulatory requirements relating to provider notification. If there is a discrepancy between the effective date of this clinical policy and any applicable legal or regulatory requirement, the requirements of law and regulation shall govern. The Health Plan retains the right to change, amend or withdraw this clinical policy, and additional clinical policies may be developed and adopted as needed, at any time.

CLINICAL POLICY Cosmetic and Reconstructive Procedures

This clinical policy does not constitute medical advice, medical treatment or medical care. It is not intended to dictate to providers how to practice medicine. Providers are expected to exercise professional medical judgment in providing the most appropriate care, and are solely responsible for the medical advice and treatment of members/enrollees. This clinical policy is not intended to recommend treatment for members/enrollees. Members/enrollees should consult with their treating physician in connection with diagnosis and treatment decisions.

Providers referred to in this clinical policy are independent contractors who exercise independent judgment and over whom the Health Plan has no control or right of control. Providers are not agents or employees of the Health Plan.

This clinical policy is the property of the Health Plan. Unauthorized copying, use, and distribution of this clinical policy or any information contained herein are strictly prohibited. Providers, members/enrollees and their representatives are bound to the terms and conditions expressed herein through the terms of their contracts. Where no such contract exists, providers, members/enrollees and their representatives agree to be bound by such terms and conditions by providing services to members/enrollees and/or submitting claims for payment for such services.

Note: For Medicaid members/enrollees, when state Medicaid coverage provisions conflict with the coverage provisions in this clinical policy, state Medicaid coverage provisions take precedence. Please refer to the state Medicaid manual for any coverage provisions pertaining to this clinical policy.

Note: For Medicare members/enrollees, to ensure consistency with the Medicare National Coverage Determinations (NCD) and Local Coverage Determinations (LCD), all applicable NCDs, LCDs and Medicare Coverage Articles should be reviewed prior to applying the criteria set forth in this clinical policy. Refer to the CMS website at http://www.cms.gov for additional information.

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.